loadpatents
name:-0.058559894561768
name:-0.031888961791992
name:-0.035546064376831
Maier; Martin A. Patent Filings

Maier; Martin A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Maier; Martin A..The latest application filed is for "angiopoietin-like 3 (angptl3) irna compositions and methods of use thereof".

Company Profile
32.32.54
  • Maier; Martin A. - Belmont MA
  • MAIER; Martin A. - Cambridge MA
  • Maier; Martin A. - Carlsbad CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Grant 11,419,942 - Foster , et al. August 23, 2
2022-08-23
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
Grant 11,408,001 - Fitzgerald , et al. August 9, 2
2022-08-09
Angiopoietin-like 3 (angptl3) Irna Compositions And Methods Of Use Thereof
App 20220119815 - Querbes; William ;   et al.
2022-04-21
Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases
Grant 11,286,486 - Zimmermann , et al. March 29, 2
2022-03-29
COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20220090068 - Fitzgerald; Kevin ;   et al.
2022-03-24
Compositions And Methods For Inhibition Of Expression Of Apolipoprotein C-iii (apoc3) Genes
App 20220049253 - Bettencourt; Brian ;   et al.
2022-02-17
Compositions And Methods For Inhibition Of Expression Of Protein C (proc) Genes
App 20210388360 - Toudjarska; Ivanka ;   et al.
2021-12-16
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
Grant 11,198,872 - Querbes , et al. December 14, 2
2021-12-14
Complement component C5 iRNA compositions and methods of use thereof
Grant 11,162,098 - Fitzgerald , et al. November 2, 2
2021-11-02
HEPATITIS B VIRUS (HBV) dsRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF
App 20210332365 - JADHAV; Vasant R. ;   et al.
2021-10-28
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210317452 - Sehgal; Alfica ;   et al.
2021-10-14
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
Grant 11,142,766 - Fitzgerald , et al. October 12, 2
2021-10-12
Compositions and methods for inhibition of expression of protein C (PROC) genes
Grant 11,118,181 - Toudjarska , et al. September 14, 2
2021-09-14
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210269796 - Schlegel; Mark K. ;   et al.
2021-09-02
SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210254063 - Akinc; Akin ;   et al.
2021-08-19
TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210254076 - Butler; James ;   et al.
2021-08-19
Factor XII (Hageman Factor) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), and Kininogen 1 (KNG1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210246447 - Akinc; Akin ;   et al.
2021-08-12
Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
Grant 11,034,958 - Fitzgerald , et al. June 15, 2
2021-06-15
TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210163952 - Butler; James ;   et al.
2021-06-03
Serpina1 iRNA compositions and methods of use thereof
Grant 10,995,336 - Schlegel , et al. May 4, 2
2021-05-04
TMPRSS6 iRNA compositions and methods of use thereof
Grant 10,988,768 - Butler , et al. April 27, 2
2021-04-27
APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210108203 - Fitzgerald; Kevin ;   et al.
2021-04-15
Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof
Grant 10,934,544 - Akinc , et al. March 2, 2
2021-03-02
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20210046187 - Foster; Donald ;   et al.
2021-02-18
Serpina1 iRNA compositions and methods of use thereof
Grant 10,920,223 - Sehgal , et al. February 16, 2
2021-02-16
TMPRSS6 iRNA compositions and methods of use thereof
Grant 10,913,950 - Butler , et al. February 9, 2
2021-02-09
TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200392511 - Butler; James ;   et al.
2020-12-17
TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES
App 20200377889 - Zimmermann; Tracy ;   et al.
2020-12-03
TMPRSS6 iRNA compositions and methods of use thereof
Grant 10,829,763 - Butler , et al. November 10, 2
2020-11-10
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
Grant 10,814,007 - Foster , et al. October 27, 2
2020-10-27
Rnai Agents, Compositions And Methods Of Use Thereof For Treating Transthyretin (ttr) Associated Diseases
App 20200318111 - Rajeev; Kallanthottathil G. ;   et al.
2020-10-08
HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200291405 - Hinkle; Gregory ;   et al.
2020-09-17
Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes
App 20200263176 - Bettencourt; Brian ;   et al.
2020-08-20
Compositions And Methods For Inhibitiion Of Expression Of Protein C (proc) Genes
App 20200239890 - Toudjarska; Ivanka ;   et al.
2020-07-30
Angiopoietin-like 3 (angptl3) Irna Compositions And Methods Of Use Thereof
App 20200224201 - Querbes; William ;   et al.
2020-07-16
SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200216844 - Akinc; Akin ;   et al.
2020-07-09
APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200199591 - Fitzgerald; Kevin ;   et al.
2020-06-25
Serpina1 iRNA compositions and methods of use thereof
Grant 10,683,504 - Sehgal , et al.
2020-06-16
Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases
Grant 10,683,501 - Zimmermann , et al.
2020-06-16
FACTOR XII (HAGEMAN FACTOR) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), AND KININOGEN 1 (KNG1) iRNA COMPOSITIONS AN
App 20200131513 - Akinc; Akin ;   et al.
2020-04-30
APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200080088 - Fitzgerald; Kevin ;   et al.
2020-03-12
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200080085 - Sehgal; Alfica ;   et al.
2020-03-12
Compositions And Methods For Inhibitiion Of Expression Of Protein C (proc) Genes
App 20200056175 - Toudjarska; Ivanka ;   et al.
2020-02-20
COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20200032259 - Fitzgerald; Kevin ;   et al.
2020-01-30
TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES
App 20190345492 - Zimmermann; Tracy ;   et al.
2019-11-14
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20190316127 - Schlegel; Mark K. ;   et al.
2019-10-17
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20190298842 - Foster; Donald ;   et al.
2019-10-03
TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20190284562 - Butler; James ;   et al.
2019-09-19
TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20190211341 - Butler; James ;   et al.
2019-07-11
METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA
App 20190153443 - Fitzgerald; Kevin ;   et al.
2019-05-23
Compositions and methods for inhibition of expression of protein C (PROC) genes
Grant 10,273,478 - Toudjarska , et al.
2019-04-30
Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes
App 20180362978 - Bettencourt; Brian ;   et al.
2018-12-20
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20180346910 - Sehgal; Alfica ;   et al.
2018-12-06
Methods for increasing efficacy of lipid formulated siRNA
Grant 10,053,689 - Fitzgerald , et al. August 21, 2
2018-08-21
Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes
Grant 9,970,006 - Bettencourt , et al. May 15, 2
2018-05-15
Compositions and Methods for Inhibition of Expression of Protein C (PROC) Genes
App 20180066255 - Toudjarska; Ivanka ;   et al.
2018-03-08
Compositions and methods for inhibition of expression of protein C (PROC) genes
Grant 9,725,718 - Toudjarska , et al. August 8, 2
2017-08-08
Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes
App 20160333342 - Bettencourt; Brian ;   et al.
2016-11-17
Compositions and methods for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression
App 20160186172 - Bettencourt; Brian ;   et al.
2016-06-30
METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA
App 20160024498 - Fitzgerald; Kevin ;   et al.
2016-01-28
Compositions and Methods for Inhibition of Expression of Protein C (PROC) Genes
App 20160024499 - Toudjarska; Ivanka ;   et al.
2016-01-28
Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression
Grant 9,228,188 - Bettencourt , et al. January 5, 2
2016-01-05
Serpinc1 iRNA compositions and methods of use thereof
Grant 9,127,274 - Akinc , et al. September 8, 2
2015-09-08
Compositions and methods for inhibition of expression of protein C (PROC) genes
Grant 9,068,184 - Toudjarska , et al. June 30, 2
2015-06-30
Methods for increasing efficacy of lipid formulated siRNA
Grant 9,051,567 - Fitzgerald , et al. June 9, 2
2015-06-09
Compositions and Methods for Inhibition of Expression of Protein C (PROC) Genes
App 20140142162 - Toudjarska; Ivanka ;   et al.
2014-05-22
Compositions and Method for Inhibiting Hepcidin Antimicrobial Peptide (HAMP) or HAMP-Related Gene Expression
App 20140127325 - Bettencourt; Brian ;   et al.
2014-05-08
SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
App 20130317081 - Akinc; Akin ;   et al.
2013-11-28
Methods For Increasing Efficacy of Lipid Formulated siRNA
App 20120244207 - Fitzgerald; Kevin ;   et al.
2012-09-27
Oligomers comprising activated disulfides which bind to plasma proteins and their use for delivery to cells
Grant 7,713,944 - Kinberger , et al. May 11, 2
2010-05-11
Oligomeric compositions and methods
App 20060142232 - Kinberger; Garth A. ;   et al.
2006-06-29
Method for sequential support-bound synthesis of conjugated oligomeric compounds
Grant 7,038,037 - Maier , et al. May 2, 2
2006-05-02
Novel peptide-conjugated oligomeric compounds
App 20050106598 - Manoharan, Muthiah ;   et al.
2005-05-19
Peptide-conjugated oligomeric compounds
Grant 6,878,805 - Manoharan , et al. April 12, 2
2005-04-12
Polyalkyleneamine-containing oligomers
App 20040019000 - Manoharan, Muthiah ;   et al.
2004-01-29
Method for sequential support-bound synthesis of conjugated oligomeric compounds
App 20040006203 - Maier, Martin A. ;   et al.
2004-01-08
Nuclease resistant chimeric oligonucleotides
App 20030175906 - Manoharan, Muthiah ;   et al.
2003-09-18
Nuclease resistant chimeric oligonucleotides
App 20030158403 - Manoharan, Muthiah ;   et al.
2003-08-21
Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds
App 20030045698 - Manoharan, Muthiah ;   et al.
2003-03-06
Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds
App 20010016652 - Manoharan, Muthiah ;   et al.
2001-08-23
Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds
Grant 6,207,819 - Manoharan , et al. March 27, 2
2001-03-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed